Chronic Myeloid Leukemia - Data From EUTOS For CML Demonstrate Need For Improved Management And Dose Optimization Across Europe
One-year data from the European Treatment and Outcome Study (EUTOS) for Chronic Myeloid Leukemia (CML), presented here today, provide a clear rationale for the initiative’s program of close disease management and therapeutic monitoring.
More: continued here
Filed under: Blood on October 27th, 2008